According to the latest report by IMARC Group, titled “Fractional Flow Reserve Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global fractional flow reserve market is expected to exhibit a CAGR of 12.1% during 2022-2027.

Fractional flow reserve (FFR) is a technique that assists in coronary catheterization for measuring pressure differences across coronary artery stenosis. It evaluates the ratio between the achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. It comprises specialized guidewires that efficiently penetrate through arteries and identify blockages to determine the surgical procedures required.

Request Free Sample Report: https://www.imarcgroup.com/fractional-flow-reserve-market/requestsample

Global Fractional Flow Reserve Market Trends:

At present, healthcare professionals are relying on FFR as it is cost-effective and aids in saving lives while avoiding unnecessary surgical procedures. This represents one of the major factors creating a positive outlook for the market. Additionally, the increasing geriatric population, which is more vulnerable to cardiovascular diseases (CVDs), is driving the market. Furthermore, unhealthy eating patterns, physical inactivity, hypertension, high BMI, cholesterol, and glycemic levels are resulting in the growing prevalence of heart diseases.This, coupled with rising research and development (R&D) activities to improve overall outcomes while using FFR, is impelling market growth.

Global Fractional Flow Reserve Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • ACIST Medical Systems Inc. (Bracco S.p.A.)
  • Boston Scientific Corporation
  • CathWorks Ltd.
  • Heartflow Inc.
  • Koninklijke Philips N.V.
  • Medis Medical Imaging Systems B.V.
  • Opsens Inc.
  • Pie Medical Imaging B.V. (Esaote Group)
  • Siemens Healthineers AG
  • Terumo Medical Corporation.

The report has segmented the market on the basis on region, product, application and end user.

Breakup by Product:

  • FFR Guidewires
  • FFR Monitoring Systems

Breakup by Application:

  • Multi-Vessel Coronary Artery Disease
  • Single-Vessel Coronary Artery Disease

Breakup by End User:

  • Hospitals and Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2505&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group